Getting patients hooked on an opioid overdose antidote, then raising the price

Getting patients hooked on an opioid overdose antidote, then raising the price


First came Martin Shkreli, the brash young pharmaceutical entrepreneur who raised the price for an AIDS treatment by 5,000 percent. Then, Heather Bresch, the CEO of Mylan, who oversaw the price hike for its signature Epi-Pen to more than $600 for a twin-pack, though its active ingredient costs pennies by comparison.



from Biotech News